
    
      -  Fulvestrant will be administered by intramuscular injection on day 1, day 15 and day 29
           and then every 28 days thereafter.

        -  Participants will have a physical examination and blood work performed on each treatment
           date. After teh study treatment has been completed, the physical examinations will be
           done every three months for the first 2 years, every 6 months for years 2-5, and
           annually after 5 years.

        -  Participants may remain on study treatment until disease progression or until they
           experience serious side effects.
    
  